CDC Reports Rise in Invasive Serogroup Y Meningococcal Disease
By Physician’s Briefing Staff HealthDay Reporter
FRIDAY, March 29, 2024 -- There has been a rise in invasive meningococcal disease, mainly attributable to Neisseria meningitidis serogroup Y, according to an alert issued by the U.S. Centers for Disease Control and Prevention.
There were 422 cases of invasive meningococcal disease in 2023, the most seen since 2014. So far this year, 143 cases have already been reported, meaning meningitis infections in 2024 will likely surpass 2023 numbers, the CDC added.
Most of the cases last year did not involve meningitis, though at least 17 patients died. The infections were more common in adults ages 30 to 60 years, in Black people, and in people who have HIV, the report revealed.
The CDC alert comes after the Virginia Department of Health warned of a rise in cases linked to the same rare, serious form of meningococcal disease back in 2022.
While antibiotics can quell the infection, quick treatment is critical, the CDC said. An estimated 10 to 15 percent of infected people die, and survivors sometimes suffer deafness or amputations.
Luckily, there are vaccines that shield against meningococcal disease. The CDC recommends that all children get a meningococcal conjugate vaccine, which protects against the rising strain, around the time they enter middle school. Because vaccine protection fades, the CDC also recommends a booster dose at age 16 years. Shots are also recommended for people at higher risk, like those living where an outbreak is occurring or those with HIV infection or other immune-compromising health conditions.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Long-Term Disability Risk Seen After Childhood Bacterial Meningitis
FRIDAY, Jan. 26, 2024 -- Childhood bacterial meningitis significantly increases the risk for having at least one of seven long-term disabilities, according to a study published...
Penbraya Vaccine for Meningitis Vaccine May Be On the Way
THURSDAY, Oct. 26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive...
Meningitis Threat at Mexican Surgical Clinics
THURSDAY, June 8, 2023 -- U.S. health officials are urgently trying to reach people who have recently had medical procedures at clinics in Matamoros, Mexico, because they may be...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.